Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag Dose Ranging in Japanese Subjects with Thrombocytopenia and Chronic Liver Disease
NCT00861601Phase 2Completed
- Sponsor
- GSK
- Start
- Jan 2009
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eltrombopag in Thrombocytopenia, sponsored by GSK. Started Jan 2009; status: completed.
02
Drugs
eltrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT00861601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00861601.